February 04, 2026 a 03:43 pm

ELV: Fundamental Ratio Analysis - Elevance Health Inc.

Elevance Health Inc. Stock Analysis

Elevance Health Inc. has shown a strong performance in the healthcare industry, leveraging its comprehensive care offerings. Despite a competitive market, it maintains a robust portfolio serving millions of individuals. The company's rebranding and strategic expansions are pivotal to its sustained growth.

Fundamental Rating

The fundamental analysis indicates a strong financial stability with notable scores in Discounted Cash Flow and Return on Equity.

Category Score Score Bar
Discounted Cash Flow 5
Return on Equity 4
Return on Assets 4
Debt to Equity 1
Price to Earnings 3
Price to Book 3

Historical Rating

Historical data shows a consistent performance with a maintained overall score of 4, demonstrating stability in financial metrics.

Date Overall DCF ROE ROA D/E P/E P/B
2026-02-03 4 5 4 4 1 3 3
2025-12-03 4 5 4 4 1 3 3

Analyst Price Targets

Analyst price targets reflect optimism with the median price target slightly above current levels, indicating a potential upside.

High Low Median Consensus
425 332 394.5 387.14
Elevance Health Stock Chart

Analyst Sentiment

The consensus among analysts is generally positive, with a notable "Buy" sentiment driving the confidence in the stock's future performance.

Rating Count Distribution
Strong Buy 0
Buy 26
Hold 11
Sell 0
Strong Sell 0

Conclusion

Elevance Health Inc. demonstrates a solid financial position with strong scores in critical areas like DCF and ROE. The company's robust business model in healthcare provides a stable revenue stream. Analyst sentiment remains positive, reflecting confidence in future growth, though competition in the healthcare market poses a potential risk. Overall, the stock appears to offer significant opportunities for long-term investors while requiring vigilance to industry dynamics.